Answers are grounded in this paper and cite their sources.
Patent ductus arteriosus (PDA) remains common in very preterm infants.Paracetamol has emerged as a potential alternative to non-steroidal anti-inflammatory drugs for ductal closure, but the efficacy, safety, and clinical value of prophylactic administration remain uncertain.PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials were searched from database inception through September 2026 for prospective randomized controlled trials comparing early prophylactic acetaminophen/paracetamol with placebo, saline, or no prophylactic therapy in preterm or low-birth-weight infants.The primary outcome was persistent PDA after the initial prophylactic course.Random-effects meta-analysis was used to pool risk ratios (RRs) for dichotomous outcomes and mean differences (MDs) for continuous outcomes, and risk of bias was assessed using Cochrane Risk of Bias 2 (RoB-2).Certainty of evidence was assessed using GRADE (Grading of Recommendations Assessment, Development and Evaluation).Six randomized controlled trials encompassing 1,163 preterm infants were included.Prophylactic paracetamol reduced persistent PDA (RR = 0.43; 95% confidence interval (CI) 0.28 to 0.64; P < 0.0001; I² = 65.9%).Rescue PDA treatment did not differ significantly (RR = 0.67; 95% CI 0.45 to 1.00; P = 0.0503; I² = 37.7%).Ductal diameter (MD = -0.30mm; 95% CI -0.50 to -0.11) and left atrial-to-aortic root ratio (MD = -0.07;95% CI -0.08 to -0.06) were also reduced.No statistically significant differences were observed in surgical PDA closure, mortality, bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, retinopathy of prematurity, sepsis, culture-positive sepsis, duration of mechanical ventilation, or length of hospital stay.The primary effect remained directionally and statistically robust in leave-one-out analyses and in the analysis restricted to intravenous/parenteral regimens.Early prophylactic paracetamol accelerates anatomical ductal closure without a demonstrated reduction in subsequent rescue treatment, but the available randomized evidence does not demonstrate improvement in major patientcentered neonatal outcomes.These findings do not support routine universal prophylaxis; adequately powered trials of targeted treatment strategies with long-term safety and neurodevelopmental follow-up are needed.
No takes yet. Share an insight, caveat, or question.
Hussamaldin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: